Case Report: Late Identification of Children with Complete Kawasaki Disease with Left Coronary Artery Aneurysm in Remote Area: Kutai Barat
DOI:
https://doi.org/10.38035/jim.v4i4.1249Keywords:
Kawasaki disease, aortic aneurysm, early identification, echocardiographyAbstract
This case report discusses a 6-year-old child with Kawasaki disease and findings of an aortic aneurysm. The patient's complaints and clinical presentation raised suspicion of Kawasaki disease. Although delayed, an echocardiogram was performed approximately one week after the onset of symptoms to assess potential complications that could worsen if left undetected. This case report emphasizes the significance of diagnostic imaging in detecting cardiac complications in Kawasaki disease cases, as well as the importance of follow-up examination and treatment planning for the patient. Despite limitations in facilities and access, this case report emphasizes that monitoring echocardiographic findings supports the prevention of worsening aneurysms.
References
Mayasari, R., -, F. and K, S. (2019) “PENYAKIT KAWASAKI”, Media Dermato-Venereologica Indonesiana, 46(2).
Srinivasan R, Weller R, Chelliah A, Einstein AJ. Multimodality cardiac imaging in a patient with Kawasaki disease and giant aneurysms Case Rep Pediatr. 2016;2016:4298098
Hoshino S, Tsuda E, Yamada O. Characteristics and Fate of Systemic Artery Aneurysm after Kawasaki Disease. J Pediatr 2015;167(1):108–112. e1–e2.
Ghareep AN, Alkuwari M, Willington F, Szmigielski W. Kawasaki disease: Diagnosis and follow-Up by CT coronary angiography with the use of 128-slice dual source dual energy scanner. A case report Pol J Radiol. 2015;80:526–8
McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation 2017;135(17):e927–e999
Onouchi Y. Genetics of Kawasaki disease: what we know and don’t know. Circ J. 2012;76:1581–1586.
JCS Joint Working Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2008): digest version. Circ J. 2010;74:1989–2020.
Newburger JW, Takahashi M, Burns JC. Kawasaki Disease. J Am Coll Cardiol 2016;67(14):1738–1749.
Kanai T, Ishiwata T, Kobayashi T, et al. Ulinastatin, a urinary trypsin inhibitor, for the initial treatment of patients with Kawasaki disease: a retrospective study. Circulation 2011;124(25):2822–2828
Friedman KG, Gauvreau K, Hamaoka-Okamoto A, et al. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population. J Am Heart Assoc 2016;5(9):e003289.
McCrindle BW, Li JS, Minich LL, et al. Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation 2007;116(2):174–179.
de Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr. 1998;133:254–258.
Marchesi A, Tarissi de Jacobis I, Rigante D, et al. Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase. Ital J Pediatr 2018;44(1):102.
Onouchi Z, Shimazu S, Kiyosawa N, Takamatsu T, Hamaoka K. Aneurysms of the coronary arteries in Kawasaki disease. An angiographic study of 30 cases. Circulation 1982;66(1):6–13.
Sumitomo N, Karasawa K, Taniguchi K, Ichikawa R, Fukuhara J, Abe O, Miyashita M, Kanamaru H, Ayusawa M, Harada K. Association of sinus node dysfunction, atrioventricular node conduction abnormality and ventricular arrhythmia in patients with Kawasaki disease and coronary involvement. Circ J. 2008;72:274–280.
Kuwabara M, Yashiro M, Ae R, Yanagawa H, Nakamura Y. The effects of early intravenous immunoglobulin therapy for Kawasaki disease: The 22nd nationwide survey in Japan. Int J Cardiol 2018;269(334):338.
Oates-Whitehead RM, Baumer JH, Haines L, Love S, Maconochie IK, Gupta A, Roman K, Dua JS, Flynn I. Intravenous immunoglobulin for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev. 2003;(4):CD004000.
Baumer JH, Love SJ, Gupta A, Haines LC, Maconochie I, Dua JS. Salicylate for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev. 2006;(4):CD004175.
Gerschutz GP, Bhatt DL; Clopidogrel in Unstable Angina to Prevent Recurrent Events study. The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study: to what extent should the results be generalizable? Am Heart J. 2003;145:595–601.
Sugahara Y, Ishii M, Muta H, Iemura M, Matsuishi T, Kato H. Warfarin therapy for giant aneurysm prevents myocardial infarction in Kawasaki disease. Pediatr Cardiol. 2008;29:398–401.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Reiny Laura Ningrum, Zainal Fathurohim, Ika Maya Sandy
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share— copy and redistribute the material in any medium or format
- Adapt— remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution— You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions— You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
- You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
- No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rightsmay limit how you use the material.
